AI-Driven Decentralized Disease Surveillance and Diagnostic Platform
Legal Citation
Summary of the Inventive Concept
A decentralized, AI-powered disease surveillance and diagnostic platform leveraging collapsible fluid collection devices with integrated microfluidic chips and wireless communication capabilities for real-time sample analysis and remote monitoring.
Background and Problem Solved
The original patent addressed the need for early diagnosis in medical diagnostic tests, particularly in communicable diseases. However, it did not provide a comprehensive solution for decentralized disease surveillance and remote monitoring. The new inventive concept solves this problem by integrating AI-driven analytics, microfluidic chips, and wireless communication capabilities into a decentralized platform, enabling real-time disease monitoring and predictive modeling.
Detailed Description of the Inventive Concept
The AI-driven decentralized disease surveillance and diagnostic platform consists of a network of collapsible fluid collection devices, each equipped with a microfluidic chip for real-time sample analysis and wireless communication capabilities for transmitting results to a centralized database. The platform utilizes machine learning algorithms to analyze data from the devices, identify trends and patterns, and generate predictive models for disease outbreaks. Additionally, the platform includes an AI-powered diagnostic engine for interpreting results and providing personalized treatment recommendations. The system enables remote, telemedicine-based disease diagnosis and continuous bodily fluid monitoring through wearable, implantable, or injectable devices.
Novelty and Inventive Step
The new inventive concept introduces the integration of AI-driven analytics, microfluidic chips, and wireless communication capabilities into a decentralized disease surveillance and diagnostic platform, which is not present in the original patent. The inventive step lies in the combination of these components to enable real-time disease monitoring, predictive modeling, and personalized treatment recommendations.
Alternative Embodiments and Variations
Alternative embodiments of the platform could include the use of different types of microfluidic chips, various wireless communication protocols, or integration with existing electronic health record systems. Variations could also include the development of specialized devices for specific diseases or applications, such as infectious disease monitoring or cancer diagnosis.
Potential Commercial Applications and Market
The AI-driven decentralized disease surveillance and diagnostic platform has significant commercial potential in the healthcare industry, particularly in the fields of infectious disease monitoring, personalized medicine, and remote patient monitoring. The platform could be marketed to healthcare providers, research institutions, and government agencies, with potential applications in disease outbreak response, clinical trials, and public health surveillance.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B10/007 |
| A | A61 | A61B5/150755 |
| A | A61 | A61B10/0051 |
| A | A61 | A61B5/150343 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical diagnostics, point-of-care testing, microfluidic sample collection systems, with expertise in biomedical engineering, microfluidics, and diagnostic device design
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with advanced degree, experience in microfluidic systems, familiarity with point-of-care diagnostic technologies, and knowledge of wireless communication and data transmission protocols
Obviousness Rationale
A PHOSITA would recognize that integrating wireless communication, microfluidic analysis, and AI-driven diagnostics into a collapsible fluid collection system represents a predictable technological extension of the source patent's core design. The fundamental structure of a collapsible diagnostic container provides a natural platform for adding advanced sensing and communication technologies. These enhancements represent incremental improvements using known techniques in medical diagnostic systems.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,169 |
|---|---|
| Title | Collapsible fluid collection system for point-of-care diagnostics |
| Assignee(s) | George Mason Research Foundation, Inc. |